Loading viewer...
investor_presentation
Format: PDF investor_presentation
Myokardia management presentation from March 2017 outlining clinical development programs for MYK-461 and MYK-491, advancing precision cardiovascular medicine. The presentation discusses the Phase 2 PIONEER-HCM trial and collaboration with Sanofi to develop novel therapies for serious cardiovascular disease.
presentation
investor_presentation
18 Pages
CIC Holdings PLC
AGBA Group Q1 2023 Financial Results Presentation
investor_presentationinvestor_presentation
32 Pages
AGBA Group Holding Limited